These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 22895666)

  • 1. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease.
    Rask-Madsen C; Kahn CR
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2052-9. PubMed ID: 22895666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking metabolic dysfunction with cardiovascular diseases: Brn-3b/POU4F2 transcription factor in cardiometabolic tissues in health and disease.
    Budhram-Mahadeo VS; Solomons MR; Mahadeo-Heads EAO
    Cell Death Dis; 2021 Mar; 12(3):267. PubMed ID: 33712567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
    Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What fans the fire: insights into mechanisms of leptin in metabolic syndrome-associated heart diseases.
    Dong M; Ren J
    Curr Pharm Des; 2014; 20(4):652-8. PubMed ID: 23688014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance, metabolic stress, and atherosclerosis.
    Pansuria M; Xi H; Li L; Yang XF; Wang H
    Front Biosci (Schol Ed); 2012 Jan; 4(3):916-31. PubMed ID: 22202099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
    Sowers JR; Whaley-Connell A; Epstein M
    Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and cardiovascular disease: state of the art?
    Szmitko PE; Teoh H; Stewart DJ; Verma S
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1655-63. PubMed ID: 17142348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture.
    King GL; Park K; Li Q
    Diabetes; 2016 Jun; 65(6):1462-71. PubMed ID: 27222390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Changes Related to Metabolic Syndrome: Evidence in Obese Zucker Rats.
    Martinelli I; Tomassoni D; Moruzzi M; Roy P; Cifani C; Amenta F; Tayebati SK
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and the endothelium.
    Quiñones MJ; Nicholas SB; Lyon CJ
    Curr Diab Rep; 2005 Aug; 5(4):246-53. PubMed ID: 16033673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin action and resistance in obesity and type 2 diabetes.
    Czech MP
    Nat Med; 2017 Jul; 23(7):804-814. PubMed ID: 28697184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for phytoinsulins as cardiovascular protector in metabolic syndrome.
    Ji L; Xing W; Dong L; Gao F
    Curr Pharm Des; 2013; 19(27):4848-58. PubMed ID: 23323618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into insulin action and resistance in the vasculature.
    Manrique C; Lastra G; Sowers JR
    Ann N Y Acad Sci; 2014 Apr; 1311(1):138-50. PubMed ID: 24650277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.
    Forst T; Hohberg C; Pfützner A
    Horm Metab Res; 2009 Feb; 41(2):123-31. PubMed ID: 19214922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.
    Meshkani R; Adeli K
    Clin Biochem; 2009 Sep; 42(13-14):1331-46. PubMed ID: 19501581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.
    Zhou MS; Schulman IH; Zeng Q
    Vasc Med; 2012 Oct; 17(5):330-41. PubMed ID: 22814999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Rho proteins by phosphorylation in the cardiovascular system.
    Loirand G; Guilluy C; Pacaud P
    Trends Cardiovasc Med; 2006 Aug; 16(6):199-204. PubMed ID: 16839863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and molecular basis of insulin resistance.
    Chakraborty C
    Curr Protein Pept Sci; 2006 Apr; 7(2):113-21. PubMed ID: 16611137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance as the underlying cause for the metabolic syndrome.
    Lann D; LeRoith D
    Med Clin North Am; 2007 Nov; 91(6):1063-77, viii. PubMed ID: 17964909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.